Epivax Therapeutics Inc.

Providence, RI Part of Epivax Inc.

UEI: YLPUE9JLKUR6
CAGE: 95Z26
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Active through Mar 17, 2027

Company facts

Self-certified in SAM.gov: For Profit Organization

Woman Owned Small Business

Woman Owned Business
Entity structure: Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov: 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary

541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Corporate family: Epivax Inc. Parent NLAVQM513F18

Epivax Therapeutics Inc. YLPUE9JLKUR6
SAM.gov registration date: Sep 17, 2021
Physical address: 188 Valley St #424, Providence, RI 02909, USA
Website: epivaxtx.com
Founded: 2017
Employees: 1-10
Estimated annual revenue: $0-$1M
Industry: Health Care

Pharmaceuticals, Biotechnology & Life Sciences

Pharmaceuticals
SIC code: 28 Chemical & Allied Products
Profiles: LinkedIn

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Mar 27, 2026.

Epivax Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is YLPUE9JLKUR6.

Epivax Therapeutics Inc.'s CAGE code is 95Z26.

Epivax Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Epivax Therapeutics Inc.'s physical address in SAM.gov is 188 Valley St #424, Providence, RI 02909, USA.

Yes. Epivax Therapeutics Inc.'s SAM.gov registration is active through March 17, 2027.

Epivax Therapeutics Inc. is part of Epivax Inc.

On GovTribe

Try for free Login